MRGGX
Price
$45.69
Change
+$0.03 (+0.07%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.09 (-0.06%)
Updated
Nov 13 closing price
Ad is loading...

MRGGX vs VTSAX

Header iconMRGGX vs VTSAX Comparison
Open Charts MRGGX vs VTSAXBanner chart's image
MFS Core Equity R1
Price$45.69
Change+$0.03 (+0.07%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.09 (-0.06%)
VolumeN/A
CapitalizationN/A
MRGGX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRGGX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRGGX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. MRGGX (7B). VTSAX pays higher dividends than MRGGX: VTSAX (1.35) vs MRGGX (0.33). MRGGX was incepted earlier than VTSAX: MRGGX (20 years) vs VTSAX (24 years). MRGGX is a more actively managed with annual turnover of: 35.00 vs. VTSAX (2.00). MRGGX has a lower initial minimum investment than VTSAX: MRGGX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. MRGGX (30.57). VTSAX return over 5 years is better than : 87.46 vs. MRGGX (58.37).
MRGGXVTSAXMRGGX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD22.57724.89191%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets7B1.73T0%
Annual Yield % from dividends0.331.3524%
Returns for 1 year30.5733.3992%
Returns for 3 years6.7222.8229%
Returns for 5 years58.3787.4667%
Returns for 10 years71.44194.0737%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals